Literature DB >> 11562868

[Correlation between the expression of proinflammatory cytokines and matrix metalloproteinases in the acute phase of an ischemic stroke].

J Montaner1, J Alvarez-Sabín, G Barberá, A Anglés, C Molina, S Abilleira, J Arenillas, P Chacón, J Monasterio.   

Abstract

INTRODUCTION: Proinflammatory cytokines are the main responsible for the onset of postischemic inflammatory cascade. Recently, the deleterious effect of matrix metalloproteinases (MMPs) in the acute phase of stroke has been described. Animal models suggest a link between both families.
OBJECTIVE: We aimed to investigate possible relations between the MMP overproduction and proinflammatory cytokine expression after human ischemic stroke. PATIENTS AND METHODS: From all consecutive stroke patients attended during a 10 months period, we selected and prospectively studied those presenting as a cardioembolic stroke involving the MCA territory. MMP 9, MMP 2 and IL 6 were serially measured by means of ELISA at study entry and at 12, 24 and 48 hours after symptoms onset.
RESULTS: A total of 39 patients were studied. A positive correlation was found between mean expression of both MMPs and IL 6 (r= 0.33, p= 0.040 for MMP 2 y r= 0.45, p= 0.004 for MMP 9). From all measured timepoints, the best obtained correlation was that of MMP 9 with IL 6 at 24 hours (r= 0.418, p= 0.010). At 24 h a peak value of IL 6 was observed. Baseline MMP 2 and MMP 9 levels showed a trend to correlate with that peak of IL 6 (r= 0.329, p= 0.061 for MMP 2 y r= 0.325, p= 0.061 for MMP 9).
CONCLUSION: MMP expression correlates with the inflammatory cascade activation after acute cardioembolic stroke.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11562868

Source DB:  PubMed          Journal:  Rev Neurol        ISSN: 0210-0010            Impact factor:   0.870


  6 in total

Review 1.  Inflammation, blood pressure, and stroke: an opportunity to target primary prevention?

Authors:  Mario Di Napoli; Francesca Papa
Journal:  Curr Hypertens Rep       Date:  2005-02       Impact factor: 5.369

2.  Molecular biomarkers in stroke diagnosis and prognosis.

Authors:  Matthew B Maas; Karen L Furie
Journal:  Biomark Med       Date:  2009-08-01       Impact factor: 2.851

3.  Blood-brain barrier disruption in humans is independently associated with increased matrix metalloproteinase-9.

Authors:  Taura L Barr; Lawrence L Latour; Kyung-Yul Lee; Timothy J Schaewe; Marie Luby; George S Chang; Ziad El-Zammar; Shaista Alam; John M Hallenbeck; Chelsea S Kidwell; Steven Warach
Journal:  Stroke       Date:  2009-12-24       Impact factor: 7.914

4.  Neuroprotective effects of bilobalide on cerebral ischemia and reperfusion injury are associated with inhibition of pro-inflammatory mediator production and down-regulation of JNK1/2 and p38 MAPK activation.

Authors:  Mingjin Jiang; Jing Li; Qiuxian Peng; Yi Liu; Wei Liu; Chaohua Luo; Ju Peng; Junkui Li; Ken Kin Lam Yung; Zhixian Mo
Journal:  J Neuroinflammation       Date:  2014-09-26       Impact factor: 8.322

5.  Association Between High-Sensitivity C-Reactive Protein and Prognosis in Different Periods After Ischemic Stroke or Transient Ischemic Attack.

Authors:  Yu Wang; Jiejie Li; Yuesong Pan; Mengxing Wang; Xia Meng; Yongjun Wang
Journal:  J Am Heart Assoc       Date:  2022-06-29       Impact factor: 6.106

Review 6.  Implications of MMP9 for Blood Brain Barrier Disruption and Hemorrhagic Transformation Following Ischemic Stroke.

Authors:  Renée J Turner; Frank R Sharp
Journal:  Front Cell Neurosci       Date:  2016-03-04       Impact factor: 5.505

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.